NCT03483259View on ClinicalTrials.gov

To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

May 12, 2018

Study Completion Date

May 18, 2018

Conditions

Relative Bioavailability

Interventions

DRUG

Sulfatinib T capsule

Sulfatinib T capsules were produced by Hutchison Whampoa Pharmaceutical (Suzhou) Co., Ltd. production.

DRUG

Sulfatinib R capsule

Sulfatinib R capsules were produced by Beijing Yiling Bioengineering Technology Co., Ltd.

Trial Locations (1)

200031

Shanghai Xuhui District Central Hospital, Shanghai

All Listed Sponsors

lead

Hutchison Medipharma Limited

INDUSTRY

NCT03483259 - To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers | Biotech Hunter | Biotech Hunter